Stock data
Cardiff Oncology, Inc. (CRDF)
Cardiff Oncology, Inc. (CRDF) reported revenue of US$0.59M and net income of -US$45.85M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.59M | — | -US$48.96M | -US$45.85M | — |
| 2024 | US$0.68M | — | -US$48.65M | -US$45.43M | — |
| 2023 | US$0.49M | — | -US$45.41M | -US$41.44M | — |
| 2022 | US$0.39M | — | -US$39.90M | -US$38.70M | — |
| 2021 | US$0.36M | — | -US$28.86M | -US$28.29M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.10M | -US$9.23M | — |
| 2026-03-31 | US$0.04M | -US$12.35M | — |
| 2025-12-31 | US$0.24M | -US$7.22M | — |
| 2025-09-30 | US$0.12M | -US$11.26M | — |
| 2025-06-30 | US$0.12M | -US$13.94M | — |
| 2025-03-31 | US$0.11M | -US$13.43M | — |
| 2024-12-31 | US$0.15M | -US$11.79M | — |
| 2024-09-30 | US$0.17M | -US$11.86M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.